Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
76.06
-0.88 (-1.14%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Vaxcyte Employees
Vaxcyte had 254 employees as of December 31, 2023. The number of employees increased by 96 or 60.76% compared to the previous year.
Employees
254
Change (1Y)
96
Growth (1Y)
60.76%
Revenue / Employee
n/a
Profits / Employee
-$1,719,780
Market Cap
8.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
AptarGroup | 13,800 |
Bio-Rad Laboratories | 8,030 |
Qiagen | 5,967 |
Globus Medical | 5,000 |
Legend Biotech | 1,826 |
PCVX News
- 15 hours ago - Vaxcyte Appoints John Furey to Board of Directors - GlobeNewsWire
- 7 weeks ago - Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants - GlobeNewsWire
- 4 months ago - Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - GlobeNewsWire
- 5 months ago - Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 months ago - Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference - GlobeNewsWire